
- /
- Supported exchanges
- / US
- / MSB.NYSE
Mesabi Trust (MSB NYSE) stock market data APIs
Mesabi Trust Financial Data Overview
Mesabi Trust, a royalty trust, engages in iron ore mining business in the United States. The company was incorporated in 1961 and is based in New York, New York.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Mesabi Trust (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Mesabi Trust data using free add-ons & libraries
Get Mesabi Trust Fundamental Data
Mesabi Trust Fundamental data includes:
- Net Revenue: 25 011 K
- EBITDA:
- Earnings Per Share: 7
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-09-15
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Mesabi Trust News

Mesabi Trust Press Release
NEW YORK, October 10, 2025--(BUSINESS WIRE)--Announcement of Mesabi Trust Distribution The Trustees of Mesabi Trust (NYSE:MSB) declared a distribution of thirty-four cents ($0.34) per Unit of Benefic...


Ryoncil® Revenues Increase 66% in Second Quarter Post Launch
NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced gross revenue of US$21...

Ryoncil® Revenues Increase 66% in Second Quarter Post Launch
Mesoblast Limited NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced gross...

Mesoblast (ASX:MSB): Assessing Valuation Following Recent Share Price Surge
Mesoblast (ASX:MSB) shares have delivered standout gains lately, with the stock up 42% over the past month and nearly 70% higher over the past 3 months. Investors seem to be re-evaluating the outlook....
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.